Back to News
Market Impact: 0.25
TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
Source: globenewswire.com
Healthcare & BiotechTechnology & Innovation
The P4 study, published simultaneously in NEJM, found CT-guided PCI planning using pre-procedural CCTA delivered clinical outcomes at one year that matched the comparator approach, with shorter procedures. The findings support CCTA as a tool for key PCI planning decisions; no numerical effect sizes or market reaction were reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
More News
- Sam Altman makes surprise South Korea visit as OpenAI builds on chip partnerships
- Tesla, Samsung oppose new US tariffs on Vietnam as probe deadline nears
- Companies promised AI gains— here's how the payoff showed up in earnings
- Soaring health insurance costs are quietly preventing wages from rising higher, while workers also shoulder a larger share of premiums, economist says
- Exclusive-Australian outback data centre pulls timeline after regulator stalls
- While Americans turn against data centers, Brazil offers tax breaks and cheap power, representing a potential ‘release valve’ for U.S. constraints